| Discrepancies between routine sacroiliac joint MRI reporting and current expert recommendations in patients with spondyloarthritis | RMD open |  | | 2025 | 19 | 45 |
|
| Topography of entheseal lesions on ultrasound : a comparative study between axial spondyloarthritis, psoriatic arthritis and healthy controls | RMD open | | | 2025 | 15 | 125 |
|
| Rhumatologie : ce qui a changé en 2023 | Revue médicale suisse | | | 2024 | 64 | 70 |
|
| Rhumatologie : ce qui a changé en 2022 | Revue médicale suisse | | | 2023 | 162 | 137 |
|
| Real-World Six- and Twelve-Month Drug Retention, Remission and Response Rates of Secukinumab in 2,017 Psoriatic Arthritis patients in 13 European Countries | Arthritis care & research | | | 2022 | 181 | 115 |
|
| Nouveautés en médecine 2021 - Rhumatologie | Revue médicale suisse | | | 2022 | 304 | 288 |
|
| Comparative Genetic Analysis of Psoriatic Arthritis and Psoriasis for the Discovery of Genetic Risk Factors and Risk Prediction Modeling | Arthritis & rheumatology | | | 2022 | 141 | 178 |
|
| Predictive value of anti-CarP and anti-PAD3 antibodies alone or in combination with RF and ACPA on the severity of rheumatoid arthritis | Rheumatology | | | 2021 | 386 | 579 |
|
| European bio-naïve spondyloarthritis patients initiating TNF inhibitor: Time trends in baseline characteristics, treatment retention and response | Rheumatology |  | | 2021 | 186 | 0 |
|
| Site-specific resolution of enthesitis in patients with axial spondyloarthritis treated with tumor necrosis factor inhibitors | Arthritis research & therapy | | | 2021 | 166 | 225 |
|
| Tumor Necrosis Factor Inhibitor Monotherapy Versus Combination Therapy for the Treatment of Psoriatic Arthritis: Combined Analysis of European Biologics Databases | Journal of rheumatology | | | 2021 | 180 | 0 |
|
| Greater trochanteric pain syndrome: predicting who will respond to a local glucocorticoid injection | Scandinavian Journal of Rheumatology | | | 2021 | 268 | 0 |
|
| Guselkumab: the First Selective IL-23 Inhibitor for Active Psoriatic Arthritis in Adults | Expert review of clinical immunology | | | 2021 | 153 | 0 |
|
| Detectable anti-proteinase-3 antibodies precede clinical manifestations in a case of anti-neutrophil cytoplasmic antibody-associated vasculitis | Scandinavian journal of rheumatology | | | 2021 | 227 | 0 |
|
| Effectiveness and treatment retention of TNF inhibitors when used as monotherapy versus comedication with csDMARDs in 15 332 patients with psoriatic arthritis. Data from the EuroSpA collaboration | Annals of the rheumatic diseases | | | 2021 | 188 | 149 |
|
| Factors influencing the retention rates of Tumour Necrosis Factor inhibitors in patients with axial spondyloarthritis | | | | 2020 | 324 | 146 |
|
| Serum calprotectin: a promising biomarker in rheumatoid arthritis and axial spondyloarthritis | Arthritis Research and Therapy | | | 2020 | 422 | 617 |
|
| Differences between men and women with nonradiographic axial spondyloarthritis: clinical characteristics and treatment effectiveness in a real-life prospective cohort | Arthritis research & therapy | | | 2020 | 137 | 180 |
|
| Impact of acute inflammation on cytochromes P450 activity assessed by the Geneva Cocktail | Clinical Pharmacology and Therapeutics | | | 2020 | 346 | 672 |
|
| Effectiveness of secukinumab versus an alternative TNF inhibitor in patients with axial spondyloarthritis previously exposed to TNF inhibitors in the Swiss Clinical Quality Management cohort | Annals of the rheumatic diseases | | | 2020 | 177 | 0 |
|
| Impact of discordance between patient's and evaluator's global assessment on treatment outcomes in 14 868 patients with spondyloarthritis | Rheumatology | | | 2020 | 242 | 0 |
|
| Drug retention, inactive disease and response rates in 1860 patients with axial spondyloarthritis initiating secukinumab treatment: routine care data from 13 registries in the EuroSpA collaboration | RMD open | | | 2020 | 178 | 168 |
|
| Spinal radiographic progression in axial spondyloarthritis and the impact of classification as nonradiographic versus radiographic disease: Data from the Swiss Clinical Quality Management cohort | PloS one | | | 2020 | 209 | 248 |
|
| Discordances between clinical and ultrasound measurements of disease activity among RA patients followed in real life | Joint, Bone, Spine | | | 2020 | 369 | 0 |
|
| Safety and immunogenicity of tetanus/diphtheria vaccination in patients with rheumatic diseases-a prospective multi-centre cohort study | Rheumatology | | | 2019 | 317 | 0 |
|
| Synovitis in rheumatoid arthritis detected by grey scale ultrasound predicts the development of erosions over the next three years | Rheumatology | | | 2019 | 322 | 230 |
|
| Glucocorticoid injections for greater trochanteric pain syndrome: a randomised double-blind placebo-controlled (GLUTEAL) trial | Clinical Rheumatology | | | 2019 | 325 | 0 |
|
| Retention and response rates in 14 261 PsA patients starting TNF inhibitor treatment-results from 12 countries in EuroSpA | Rheumatology | | | 2019 | 283 | 0 |
|
| Reply to the letter by Prof. Rothschild. DOI: 10.1007/s10067-019-04560-y | Clinical Rheumatology | | | 2019 | 261 | 0 |
|
| Ultrasound is not associated with the presence of systemic autoimmunity or symptoms in individuals at risk for rheumatoid arthritis | RMD Open | | | 2019 | 347 | 161 |
|
| Treatment response and drug retention rates in 24 195 biologic-naïve patients with axial spondyloarthritis initiating TNFi treatment: routine care data from 12 registries in the EuroSpA collaboration | Annals of the Rheumatic Diseases | | | 2019 | 294 | 1 |
|
| Comparison of drug survival on adalimumab, etanercept, golimumab and infliximab in patients with axial spondyloarthritis | PLOS ONE | | | 2019 | 315 | 205 |
|
| Can Ultrasound Be Used to Predict Loss of Remission in Patients with RA in a Real-life Setting? A Multicenter Cohort Study | Journal of Rheumatology | | | 2018 | 458 | 0 |
|
| L'effet des traitements de fond conventionnels synthétiques en termes d'efficacité clinique et de la survie des antagonistes du facteur de nécrose tumorale dans une cohorte des patients avec une spondylarthrite axiale | | | | 2018 | 637 | 401 |
|
| Response to Tumor Necrosis Factor Inhibition in Male and Female Patients with Ankylosing Spondylitis: Data from a Swiss Cohort | Journal of Rheumatology | | | 2018 | 471 | 1 |
|
| TNF blockers inhibit spinal radiographic progression in ankylosing spondylitis by reducing disease activity: results from the Swiss Clinical Quality Management cohort | Annals of the Rheumatic Diseases | | | 2018 | 530 | 197 |
|
| Comparison of Serological Biomarkers in Rheumatoid Arthritis and Their Combination to Improve Diagnostic Performance | Frontiers in Immunology | | | 2018 | 439 | 392 |
|
| The prevalence of anticitrullinated protein antibodies increases with age in healthy individuals at risk for rheumatoid arthritis | Clinical Rheumatology | | | 2017 | 640 | 3 |
|
| Hypothesis-free analyses from a large psoriatic arthritis cohort support merger to consolidated peripheral arthritis definition without subtyping | Clinical Rheumatology | | | 2017 | 395 | 314 |
|
| Impact of obesity on the response to tumor necrosis factor inhibitors in axial spondyloarthritis | Arthritis Research and Therapy | | | 2017 | 448 | 264 |
|
| Impaired response to treatment with tumour necrosis factor α inhibitors in smokers with axial spondyloarthritis | Annals of the rheumatic diseases | | | 2016 | 606 | 0 |
|
| The Effect of Comedication With a Conventional Synthetic Disease-Modifying Antirheumatic Drug on Drug Retention and Clinical Effectiveness of Anti-Tumor Necrosis Factor Therapy in Patients With Axial Spondyloarthritis | Arthritis & rheumatology | | | 2016 | 541 | 0 |
|
| Conservative treatments for lumbar radicular pain | Current pain and headache reports | | | 2014 | 617 | 0 |
|
| Efficacy of intra-articular bevacizumab for relapsing diffuse-type giant cell tumour | Annals of the rheumatic diseases | | | 2014 | 685 | 2 |
|
| Coexistence of seropositive rheumatoid arthritis and SAPHO syndrome | Joint bone spine | | | 2013 | 651 | 0 |
|
| Replication of association of the interleukin 23 receptor rs1343151 variant with rheumatoid arthritis in Caucasian sample sets | Annals of the rheumatic diseases | | | 2012 | 590 | 0 |
|
| Tocilizumab in a patient with ankylosing spondylitis and Crohn's disease refractory to TNF antagonists | Joint bone spine | | | 2010 | 728 | 0 |
|
| Only one independent genetic association with rheumatoid arthritis within the KIAA1109-TENR-IL2-IL21 locus in Caucasian sample sets: confirmation of association of rs6822844 with rheumatoid arthritis at a genome-wide level of significance | Arthritis research & therapy | | | 2010 | 705 | 406 |
|
| The effect of alcohol on radiographic progression in rheumatoid arthritis | Arthritis and rheumatism | | | 2010 | 609 | 0 |
|
